NNOX revenueFY2025$13.02M
- FY YoY
- +15.4%
NNOX revenue was $13.02M for fiscal 2025 (ended Dec 31, 2025), up 15.4% from fiscal 2024. It rose in each of the last 4 fiscal years. Fiscal 2025 is the highest of the 5 fiscal years on file.
NANO-X IMAGING LTD (NNOX) financials
For fiscal 2025 (ended Dec 31, 2025), NANO-X IMAGING LTD reported $13.02M of revenue and -$75.02M of net income.
- Revenue, FY2025
- $13.02M
- Revenue growth, YoY
- +15.4%
- Net income, FY2025
- -$75.02M
- Net margin
- -576.1%
- Free cash flow, FY2025
- -$45.00M
- EPS, diluted, FY2025
- -$1.16
- Cash
- $49.15M
- P/S
- 1.48
- Market cap
- $19.2M
FY2021FY2025
FY2018FY2025
FY2018FY2025
NNOX revenue and earnings growth
NNOX net incomeFY2025-$75.02M
NNOX net income was -$75.02M for fiscal 2025 (ended Dec 31, 2025), compared with -$53.52M in fiscal 2024.
NNOX EPSFY2025-$1.16
NNOX diluted EPS was -$1.16 for fiscal 2025 (ended Dec 31, 2025), compared with -$0.91 in fiscal 2024.
NNOX free cash flowFY2025-$45.00M
NNOX free cash flow was -$45.00M for fiscal 2025 (ended Dec 31, 2025), compared with -$39.37M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.02M | $11.28M | $9.90M | $8.58M | $1.30M | - | - | - |
| Cost of revenue | $25.81M | $21.89M | $16.50M | $15.46M | $2.82M | - | - | - |
| Gross profit | -$12.79M | -$10.61M | -$6.59M | -$6.88M | -$1.51M | - | - | - |
| Research and development | $19.24M | $20.18M | $26.05M | $26.51M | $17.12M | $9.21M | $2.72M | $672.0K |
| Selling, general and admin | $21.59M | $22.45M | $24.27M | $41.25M | $34.71M | $22.27M | $18.30M | $1.02M |
| Operating income | -$78.23M | -$56.75M | -$62.59M | -$117.71M | -$61.56M | -$43.92M | -$22.57M | -$1.90M |
| Pre-tax income | -$76.81M | -$53.87M | -$61.12M | -$116.92M | -$61.85M | -$43.81M | -$22.56M | - |
| Income tax | -$1.79M | -$358.0K | -$339.0K | -$3.68M | -$48.0K | - | - | - |
| Net income | -$75.02M | -$53.52M | -$60.78M | -$113.24M | -$61.80M | -$43.81M | -$22.56M | -$1.91M |
| EPS, basic | -$1.16 | -$0.91 | -$1.08 | -$2.17 | -$1.28 | -$1.23 | -$0.90 | -$0.09 |
| EPS, diluted | -$1.16 | -$0.91 | -$1.08 | -$2.17 | -$1.28 | -$1.23 | -$0.90 | -$0.09 |
| Diluted shares | 64,790 | 58,673 | 56,368 | 52.2M | - | 35.7M | 25.2M | 20.8M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $49.15M | $39.30M | $56.38M | $38.46M | $66.64M | $213.47M | $8.22M | $5.0K |
| Short-term investments | - | $18.40M | $26.01M | $39.16M | $22.07M | - | - | - |
| Inventory | $3.07M | $1.49M | $2.36M | - | $116.0K | - | - | - |
| Current assets | $66.79M | $78.68M | $88.64M | $82.46M | $94.86M | $219.79M | $9.64M | - |
| Goodwill | $316.0K | - | - | $7.42M | $58.30M | - | - | - |
| Total assets | $162.16M | $210.00M | $218.65M | $253.93M | $363.17M | $236.15M | $11.87M | - |
| Current liabilities | $16.89M | $13.97M | $15.52M | $25.07M | $52.75M | $4.48M | $20.26M | - |
| Short-term debt | $3.14M | $3.06M | $3.49M | - | $145.0K | - | - | - |
| Long-term debt | - | - | - | $3.48M | - | - | - | - |
| Total debt | - | - | - | $3.48M | - | - | - | - |
| Total liabilities | $22.43M | $20.88M | $23.13M | $37.25M | $71.02M | $5.40M | $20.65M | - |
| Shareholders' equity | $139.73M | $189.12M | $195.51M | $216.68M | $292.15M | $230.75M | -$8.78M | -$6.38M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$40.79M | -$36.60M | -$44.78M | -$43.38M | -$38.06M | -$21.61M | -$5.52M | -$3.67M |
| Capital expenditures | $4.21M | $2.77M | $3.30M | $7.17M | $23.16M | $13.94M | $125.0K | $73.0K |
| Free cash flow | -$45.00M | -$39.37M | -$48.08M | -$50.56M | -$61.22M | -$35.55M | -$5.65M | -$3.74M |
| Investing cash flow | $29.37M | -$20.05M | $35.43M | $14.61M | -$116.32M | -$13.94M | -$125.0K | -$73.0K |
| Financing cash flow | $21.37M | $39.50M | $27.25M | $804.0K | $7.38M | $240.99M | $13.86M | $3.68M |
| Stock-based compensation | $4.19M | $7.26M | $6.84M | $18.62M | $18.81M | $24.78M | $16.25M | $115.0K |
| Depreciation and amortization | - | - | - | - | - | $208.0K | - | - |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 15.4% | 13.9% | 15.5% | 557.8% | - | - | - | - |
| Gross margin | -98.2% | -94.0% | -66.6% | -80.2% | -116.0% | - | - | - |
| Operating margin | -600.8% | -502.9% | -631.9% | -1372.2% | -4720.7% | - | - | - |
| Net margin | -576.1% | -474.3% | -613.6% | -1320.2% | -4739.1% | - | - | - |
| Free cash flow margin | -345.6% | -348.9% | -485.4% | -589.4% | -4694.7% | - | - | - |
| Return on equity | -53.7% | -28.3% | -31.1% | -52.3% | -21.2% | -19.0% | - | - |
| Return on assets | -46.3% | -25.5% | -27.8% | -44.6% | -17.0% | -18.6% | -190.1% | - |
| Current ratio | 3.96 | 5.63 | 5.71 | 3.29 | 1.80 | 49.06 | 0.48 | - |
| Debt to equity | - | - | - | 0.02 | - | - | - | - |
Source: XBRL data NANO-X IMAGING LTD files with the SEC, latest filing dated Apr 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
NNOX peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| NNOX | $13.02M | +15.4% | -$75.02M | -576.1% | $19.2M |
| GEHC | $21.64B | +6.9% | $2.15B | 10.0% | $37.25B |
| PHG | €17.83B | -1.0% | €895.00M | 5.0% | $29.83B |
| BFLY | $123.25M | +39.4% | -$53.69M | -43.6% | $1.70B |
NNOX FAQ
9 questionsWhat is NNOX revenue?
NANO-X IMAGING LTD (NNOX) reported $13.02M of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 15.4% from the year before.Is NNOX profitable?
No. NANO-X IMAGING LTD reported a net loss of $75.02M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does NNOX have?
NANO-X IMAGING LTD reported $49.15M in cash and cash equivalents on its most recent balance sheet in SEC filings.How fast is NNOX revenue growing?
NANO-X IMAGING LTD's revenue changed +15.4% in fiscal 2025, to $13.02M.What is NNOX gross margin?
NANO-X IMAGING LTD's gross profit was -$12.79M on $13.02M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of -98.2%.What is NNOX free cash flow?
NANO-X IMAGING LTD generated -$45.00M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -$40.79M less capital expenditures.What is NNOX earnings per share?
Diluted earnings per share were -$1.16 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did NNOX last report financial results?
The latest statements here come from NANO-X IMAGING LTD's 20-F filed on Apr 30, 2026, covering the period ended Dec 31, 2025.Where does this NNOX financial data come from?
Quantisnow builds these statements from the structured XBRL data NANO-X IMAGING LTD files with the SEC. It is provided for information only and is not investment advice.